FIM
AGIO icon

Foresters Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Foresters Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,958
Closed -$398K – 394
2017
Q4 		$398K Sell
6,958
-2,120
-23% -$133K 0.01% 419
2017
Q3 		$606K Buy
9,078
+5,178
+133% +$311K 0.01% 367
2017
Q2 		$201K Buy
+3,900
New +$199K ﹤0.01% 464

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Foresters Investment Management's AGIO Position: Q1 2018 in Review

Foresters Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2018, closing a stake of 6,958 shares — an estimated $398K sold.

Foresters Investment Management first reported a position in AGIO in Q2 2017 and held it in 3 quarters. The position peaked at $606K in Q3 2017. 198 funds tracked by Wall St. Rank hold AGIO as of Q1 2018.

  • Foresters Investment Management reported no remaining Agios Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Foresters Investment Management sold 6,958 Agios Pharmaceuticals shares in Q1 2018, an estimated $398K.
  • Foresters Investment Management first reported a position in Agios Pharmaceuticals in Q2 2017 and held it in 3 quarters.
  • Foresters Investment Management's Agios Pharmaceuticals position peaked at $606K in Q3 2017.
  • 198 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2018.

Based on Foresters Investment Management's 13F filing for Q1 2018, filed 11 May 2018.